SignalXSignalX

ARES Ares Management

FY2025 10-K
Filed: Feb 12, 2026
Health Care
Pharmaceutical PreparationsSEC EDGAR
Ares Management Overview

Ares Management (ARES) filed its fiscal year 2025 10-K annual report with the SEC on Feb 12, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • • Core business model not detailed; filing references Zoetis corporate governance and proxy statements extensively
  • • No new products, services, or segments introduced or emphasized in 2026 filing text
+3 more insights

Management Discussion & Analysis

  • • Revenue $9,467M for 2025, up 2% YoY from $9,256M in 2024
  • • Net income $2,673M, increased 8% from $2,486M in 2024; adjusted net income $2,847M, up 6% YoY
+3 more insights

Risk Factors

  • • Cybersecurity risk with potential uninsured costs despite cybersecurity insurance coverage
  • • Dependency on third-party cloud infrastructure for critical information systems operations
+3 more insights

Financial Summary
XBRL

Revenue

$9.5B

Net Income

$2.7B

Net Margin

28.2%

ROE

80.2%

Total Assets

$15.5B

EPS (Diluted)

$6.02

Operating Cash Flow

$2.9B

Source: XBRL data from Ares Management FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Ares Management

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available